000 | 01977 a2200505 4500 | ||
---|---|---|---|
005 | 20250514230123.0 | ||
264 | 0 | _c20060103 | |
008 | 200601s 0 0 eng d | ||
022 | _a0041-008X | ||
024 | 7 |
_a10.1016/j.taap.2005.03.013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLetcher, Robert J | |
245 | 0 | 0 |
_aEffects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells. _h[electronic resource] |
260 |
_bToxicology and applied pharmacology _cDec 2005 |
||
300 |
_a95-104 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenocortical Carcinoma _xenzymology |
650 | 0 | 4 |
_aAlkanes _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAromatase _xmetabolism |
650 | 0 | 4 |
_aAromatase Inhibitors _xpharmacology |
650 | 0 | 4 | _aBenzhydryl Compounds |
650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
650 | 0 | 4 |
_aCarps _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCytochrome P-450 CYP1A1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aEstradiol _xmetabolism |
650 | 0 | 4 |
_aEstrogen Receptor Modulators _xpharmacology |
650 | 0 | 4 |
_aEstrogens, Non-Steroidal _xpharmacology |
650 | 0 | 4 |
_aHepatocytes _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPhenols _xpharmacology |
650 | 0 | 4 |
_aReceptors, Aryl Hydrocarbon _xmetabolism |
650 | 0 | 4 |
_aReceptors, Estrogen _xantagonists & inhibitors |
650 | 0 | 4 |
_aTamoxifen _xpharmacology |
650 | 0 | 4 |
_aVitellogenins _xbiosynthesis |
700 | 1 | _aSanderson, J Thomas | |
700 | 1 | _aBokkers, Abraham | |
700 | 1 | _aGiesy, John P | |
700 | 1 | _avan den Berg, Martin | |
773 | 0 |
_tToxicology and applied pharmacology _gvol. 209 _gno. 2 _gp. 95-104 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2005.03.013 _zAvailable from publisher's website |
999 |
_c15569307 _d15569307 |